I hit a professional milestone today with my first senior author research manuscript getting published. So much work from so many awesome people over the past five years, but it's finally out in the world. Have a read #microbiome #cdifficile #fiber

https://www.cell.com/iscience/fulltext/S2589-0042(26)00633-4

Outbreak: Clostridium difficile (#Cdifficile)

Facility: Victoria Hospital
Facility Type: Hospital (Acute Care)
Unit/Floor/Area: C7-400 Oncology
Location: #London #Ontario
Facility Tracking Hash: #MLHU0016

Date: 2026-02-10

Public Health Unit: Middlesex-London Health Unit
PHU Tracking Hash: #OnObMLHU

Click or follow tracking hashtags to see data for individual facilities or a specific public health unit.

Outbreak: Clostridium difficile (#Cdifficile)
Facility: Michael Garron Hospital
Facility Type: Hospital (Acute Care)
Unit/Floor/Area: G6
Location: #Toronto #Ontario
Date: 2025-10-31

Public Health Unit: Toronto Public Health
Facility Tracking Hash: #TPHU0002
PHU Tracking Hash: #OnObTPHU

Click or follow tracking hashtags to see data for individual facilities or a specific public health unit.

Outbreak: Clostridium difficile (#Cdifficile)
Facility: Health Sciences North
Facility Type: Hospital (Acute Care)
Unit/Floor/Area: Intensive Care Unit (ICU): Cardio Vascular Thoracic
Location: #Sudbury #Ontario
Date: 2025-10-20

Public Health Unit: Sudbury and District Health Unit
Facility Tracking Hash: #SDHU0003
PHU Tracking Hash: #OnObSDHU

Click or follow tracking hashtags to see data for individual facilities or a specific public health unit.

Outbreak: Clostridium difficile (#Cdifficile)
Facility: Health Sciences North
Facility Type: Hospital (Acute Care)
Unit/Floor/Area: Medical-Surgical Intensive Care Unit (ICU)
Location: #Sudbury #Ontario
Date: 2025-10-17

Public Health Unit: Sudbury and District Health Unit
Facility Tracking Hash: #SDHU0003
PHU Tracking Hash: #OnObSDHU

Click or follow tracking hashtags to see data for individual facilities or a specific public health unit.

Outbreak: Clostridium difficile (#Cdifficile)
Facility: Health Sciences North
Facility Type: Hospital (Acute Care)
Unit/Floor/Area: Acute Care Reactivation Centre
Location: #Sudbury #Ontario
Date: 2025-09-21

Public Health Unit: Sudbury and District Health Unit
Facility Tracking Hash: #SDHU0003
PHU Tracking Hash: #OnObSDHU

Click or follow tracking hashtags to see data for individual facilities or a specific public health unit.

Outbreak: Clostridium difficile (#Cdifficile)
Facility: Michael Garron Hospital
Facility Type: Hospital (Acute Care)
Unit/Floor/Area: ICU
Location: #Toronto #Ontario
Date: 2025-09-11

Public Health Unit: Toronto Public Health
Facility Tracking Hash: #TPHU0002
PHU Tracking Hash: #OnObTPHU

Click or follow tracking hashtags to see data for individual facilities or a specific public health unit.

Outbreak: Clostridioides Difficile (#CDiff / #CDifficile)
Facility: Victoria Hospital
Facility Type: Hospital (Acute Care)
Unit/Floor/Area: C7-300 Oncology
Location: #London #Ontario
Date: 2025-03-17

Public Health Unit: Middlesex-London Health Unit
Facility Tracking Hash: #MLHU0016
PHU Tracking Hash: #OnObMLHU

Click or follow tracking hashtags to see data for individual facilities or a specific public health unit.

Boosts appreciated! I don’t know how much reach my dinky instance gets even on a good day.

Anyone here experienced (first hand or professionally) in dealing with c. diff. infections? My poor husband picked it up when he had surgery last month, and I want to make sure it gets gone and stays gone.

He’s got vancomycin & I picked up Saccharomyces boulardii I-745 probiotics (based on: https://cdiff.org/choosing-the-best-probiotic-for-c-diff/).

#CDiff #CDifficile #medical #ClostridioidesDifficile

Choosing the best probiotic for C. diff. - Peggy Lillis Foundation

Guest Blog by Lynne V. McFarland, PhD

Peggy Lillis Foundation
#Cdifficile is mainly treated with #vancomycin, so why is resistance not yet a problem? @BuddleJess @BrockhurstLab @RobFagan &co identify 2 resistance pathways that evolve rapidly but with fitness costs that could affect transmission #AMR #PLOSBiology https://plos.io/3YNHS1m
Identification of pathways to high-level vancomycin resistance in Clostridioides difficile that incur high fitness costs in key pathogenicity traits

Clostridioides difficile is a human pathogen primarily treated with the antibiotic vancomycin. High-level vancomycin resistance is a serious problem in other pathogens, not yet for C. difficile. This study identifies two resistance pathways in C. difficile, which evolve rapidly but with fitness costs that could affect transmission.